Bleeding Disorder therapy(Gubra ApS)

N/A

Report date: 2025/11/10 13:24:22

Base Information

Drug NameBleeding Disorder therapy(Gubra ApS)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGubra Aps
China Registration ClassN/A

Develop Information

Active CompaniesGubra ApsHemab APS
Inactive CompaniesN/A
Active IndicationsHemorrhagic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A